BSE Live
Nov 17, 16:01Prev. Close
46.50
Open Price
46.05
Bid Price (Qty.)
46.23 (2640)
Offer Price (Qty.)
46.87 (100)
NSE Live
Nov 17, 15:59Prev. Close
46.27
Open Price
46.05
Bid Price (Qty.)
46.28 (12485)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Morepen Laboratories (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Sep 17 | Mar 17 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 0.75 | 0.64 | 0.66 | 0.27 | 0.53 | |
| Diluted EPS (Rs.) | 0.75 | 0.64 | 0.66 | 0.27 | 0.53 | |
| Cash EPS (Rs.) | 1.57 | 1.53 | 1.42 | 0.00 | 1.28 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 6.31 | 5.62 | 5.01 | 0.00 | 4.35 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 6.31 | 5.62 | 5.01 | 0.00 | 4.35 | |
| Revenue from Operations/Share (Rs.) | 18.97 | 17.09 | 13.48 | 0.00 | 13.24 | |
| PBDIT/Share (Rs.) | 1.73 | 1.58 | 1.52 | 0.00 | 1.45 | |
| PBIT/Share (Rs.) | 0.91 | 0.70 | 0.76 | 0.00 | 0.69 | |
| PBT/Share (Rs.) | 0.87 | 0.65 | 0.66 | 0.00 | 0.53 | |
| Net Profit/Share (Rs.) | 0.75 | 0.64 | 0.66 | 0.00 | 0.53 | |
| NP After MI And SOA / Share (Rs.) | 0.75 | 0.64 | 0.66 | 0.00 | 0.53 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 9.14 | 9.26 | 11.28 | 11.14 | 10.93 | |
| PBIT Margin (%) | 4.81 | 4.07 | 5.62 | 5.35 | 5.23 | |
| PBT Margin (%) | 4.58 | 3.79 | 4.90 | 4.41 | 3.96 | |
| Net Profit Margin (%) | 3.93 | 3.75 | 4.90 | 4.40 | 3.96 | |
| NP After MI And SOA Margin (%) | 3.93 | 3.75 | 4.87 | 4.40 | 3.96 | |
| Return on Networth/Equity (%) | 11.82 | 11.39 | 13.09 | 0.00 | 12.04 | |
| Return on Capital Employed (%) | 13.16 | 11.33 | 13.89 | 0.00 | 14.61 | |
| Return on Assets (%) | 5.06 | 4.68 | 5.05 | 0.00 | 4.39 | |
| Total Debt/Equity (X) | 0.04 | 0.04 | 0.79 | 0.00 | 0.64 | |
| Asset Turnover Ratio (%) | 128.57 | 124.92 | 103.53 | 0.00 | 110.62 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.06 | 0.88 | 0.73 | 0.00 | 0.59 | |
| Quick Ratio (X) | 0.66 | 0.61 | 0.50 | 0.00 | 0.39 | |
| Inventory Turnover Ratio (X) | 6.16 | 8.16 | 7.89 | 0.00 | 9.21 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | 20.71 | 14.83 | 7.83 | 5.69 | 4.13 | |
| Interest Coverage Ratios (Post Tax) (%) | 20.71 | 14.83 | 7.83 | 5.69 | 4.13 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 402.04 | 754.04 | 1,559.04 | 0.00 | 972.64 | |
| EV/Net Operating Revenue (X) | 0.47 | 0.98 | 2.57 | 0.00 | 1.63 | |
| EV/EBITDA (X) | 5.15 | 10.59 | 22.78 | 0.00 | 14.94 | |
| MarketCap/Net Operating Revenue (X) | 0.50 | 1.01 | 2.29 | 0.00 | 1.44 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 1.51 | 3.07 | 6.14 | 0.00 | 4.35 | |
| Price/Net Operating Revenue | 0.50 | 1.01 | 2.29 | 0.00 | 1.44 | |
| Earnings Yield | 0.08 | 0.04 | 0.02 | 0.00 | 0.03 |
12.08.2025
Morepen Lab Consolidated June 2025 Net Sales at Rs 425.24 crore, down 6.59% Y-o-Y
07.08.2025
Morepen Lab Standalone June 2025 Net Sales at Rs 391.28 crore, up 1.46% Y-o-Y
13.05.2025
Morepen Lab Standalone March 2025 Net Sales at Rs 381.94 crore, down 2.72% Y-o-Y
12.05.2025
Morepen Lab Consolidated March 2025 Net Sales at Rs 465.85 crore, up 10.11% Y-o-Y